我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
98
9 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
已完成
42
42.9%
Enrolling By Invitation
2
2.0%
尚未招募
7
7.1%
招募中
8
8.2%
暂停
1
1.0%
终止
6
6.1%
Unknown
31
31.6%
撤回
暂无批准数据
- King Faisal Specialist Hospital & Research Centre successfully treated eight hemophilia A patients with one-time gene therapy, eliminating the need for preventive treatment and significantly improving quality of life. - The hospital became the first in Saudi Arabia to locally produce CAR-T cells in 2024, marking a major step toward national self-sufficiency in advanced cancer therapies. - KFSHRC now conducts 52.4% of all active clinical trials nationwide and recorded 701 active research proposals by the end of 2024, representing an 8% increase over the previous year.
